clavulanic acid has been researched along with beta-lactams in 102 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 43 (42.16) | 18.7374 |
1990's | 11 (10.78) | 18.2507 |
2000's | 23 (22.55) | 29.6817 |
2010's | 21 (20.59) | 24.3611 |
2020's | 4 (3.92) | 2.80 |
Authors | Studies |
---|---|
Acar, JF; Goldstein, FW; Kitzis, MD | 1 |
Labia, R; Lenfant, F; Masson, JM | 1 |
Neu, HC | 1 |
Elson, S; Southgate, R | 1 |
Ball, AP; Brookes, GR; Davey, PG; Farrell, ID; Geddes, AM | 1 |
Cole, M | 1 |
Belasco, JG; Charnas, RL; Fisher, J; Khosla, S; Knowles, JR | 1 |
D'Costa, LJ; Fast, MV; Karasira, P; Maclean, IW; Nsanze, H; Plummer, FA; Ronald, AR | 1 |
Andrews, JM; Bedford, KA; Wise, R | 1 |
Fu, KP; Neu, HC | 2 |
Andrews, JM; Patel, N; Wise, R | 1 |
Crast, LB; Gottstein, WJ; Graham, RG; Haynes, UJ; McGregor, DN | 1 |
Frère, JM; Ghuysen, JM; Kelly, JA; Klein, D | 1 |
Li, JT; Moosdeen, F; Williams, JD | 1 |
Baumgärtner, M; Wundt, W | 1 |
Bidwell, JL; Bywater, MJ; Holt, HA; Reeves, DS | 1 |
Rogers, DT; Russell, AD | 1 |
Van Klingeren, B; Van Wijngaarden, LJ | 1 |
Ansink-Schipper, MC; Coster, JF; Coutinho, RA; De Koning, GA; Tio, D | 1 |
Feng, M; Li, JT; Ma, LJ; Tao, WY; Wang, S | 1 |
O'Grady, FW | 1 |
Piot, P; Van Dyck, E | 1 |
Hashimoto, T; Matsuura, M; Mitsuhashi, S; Nakazawa, H | 1 |
Coleman, K; Fisher, J; Hunter, PA; Taylor, D | 1 |
Pohlod, DJ; Quinn, EL; Saravolatz, LD; Somerville, MM | 1 |
Cole, P; Roberts, DE | 1 |
Ivanitskaia, LP; Nikishina, VG | 1 |
Albritton, WL; Girouard, YC; Maclean, IW; Ronald, AR | 1 |
Mantoku, A; Ogawara, H | 1 |
Duez, C; Frère, JM; Ghuysen, JM; Kelly, JA | 1 |
Kusmiesz, H; Nelson, JD; Shelton, S | 1 |
Rolinson, GN | 1 |
De Klerk, HC; Forder, AA; Gricius, ME; Hallett, AF; Koornhof, HJ; Lindeque, KP; Neiteler, BF; Robinson, R; Van den Ende, J; Van Rensburg, AJ; Venter, L | 1 |
Celliers, D; Du Plessis, DJ; Lindeque, KP; Van Rensburg, AJ | 1 |
Hatzimichelakis, N; Kontomichalou, P; Makris, G; Paniara-Volika, O; Paraskevopoulou, E; Saroglou, G; Sima, A; Vassilopoulos, N | 1 |
Farmer, T; Reading, C | 2 |
Lismont, MJ; Van der Linden, MP; Yourassowsky, E | 1 |
Aoki, H; Okuhara, M | 1 |
Charnas, RL; Knowles, JR | 1 |
Ulmer, WT; Zimmermann, I | 1 |
Avery, GS; Brogden, RN; Carmine, A; Heel, RC; Morley, PA; Speight, TM | 1 |
Gaspar, MC; Soriano, F | 1 |
Amicosante, G; Fattorini, L; Franceschini, N; Frère, JM; Galleni, M; Oratore, A; Orefici, G; Quinting, B | 1 |
Frère, JM; Ghuysen, MF; Matagne, A | 1 |
Inoue, E; Mitsuhashi, S; Muratani, T; Nakane, T; Yokota, E | 1 |
Alarcón, MA; Campos, M; González, H; Sánchez, R | 1 |
Jin, YF; Piddock, LJ; Turner, HL | 1 |
Gaviraghi, G; Perboni, A; Salvatori, A; Spadoni, G; Tamburini, B; Tarzia, G; Xerri, L | 1 |
Angehrn, P; Hubschwerlen, C; Kania, M; Page, MG; Richter, HG; Specklin, JL; Winkler, FK | 1 |
Balko, T; Hoban, DJ; Karlowsky, JA; Palatnick, LP; Zhanel, GG | 1 |
Giakkoupi, P; Legakis, NJ; Tzelepi, E; Tzouvelekis, LS | 1 |
Degnan, BA; Farmer, TH; Payne, DJ | 1 |
Foustoukou, M; Lebessi, E; Legakis, NJ; Stamos, G; Tzouvelekis, LS; Vourli, S | 1 |
Jamieson, CE; Lambert, PA; Simpson, IN | 1 |
Anderson, VE; Bethel, CR; Bonomo, RA; Helfand, MS; Hujer, AM; Hujer, KM | 1 |
Fosse, T; Giraud-Morin, C; Madinier, I | 1 |
Li, C; Lister, PD; Nicolau, DP; Nightingale, CH; Quintiliani, R | 1 |
Bertrand, X; Lallemand-De-Conto, S; Talon, D; Thouverez, M | 1 |
Aguado-García, JM; Lumbreras-Bermejo, C; Martín-Herrero, JE | 1 |
Dinçer, I; Ergin, A; Kocagöz, T | 1 |
Higgins, PG; Seifert, H; Stefanik, D; Wisplinghoff, H | 1 |
Antonini, M; Carli, S; Moroni, P; Pisoni, G; Ruffo, G; Vellere, F | 1 |
Behra-Miellet, J; Calvet, L; Dubreuil, L | 1 |
Brooks, BM; Coleman, JW; Hart, CA | 1 |
Egawa, S; Endo, K; Hosobe, T; Kiyota, H; Kobayashi, I; Onodera, S; Suzuki, H; Takahashi, T | 1 |
Broide, E; Raveh, D; Rudensky, B; Yinnon, AM | 1 |
Cattoir, V; Corvec, S; Drugeon, H; Faccone, D; Galas, M; Mugnier, P; Nordmann, P; Pasteran, F; Petroni, A; Poirel, L; Rapoport, M | 1 |
Bedenic, B; Kalenic, S; Mihaljevic, Lj; Plecko, V; Sviben, M; Tonkic, M; Vranes, J | 1 |
Bonomo, RA; Buynak, JD; Carey, PR; Helfand, MS; Taracila, MA; Totir, MA; van den Akker, F | 1 |
Bonnet, R; Brebion, A; Constantin, JM; Delmas, J; Dubois, D; Robin, F | 1 |
Anuradha, K; Lakshmi, V; Sailaja, VV; Satheesh, T; Umabala, P | 1 |
Ballerini, V; Cera, G; Limansky, AS; Marchiaro, P; Morán-Barrio, J; Mussi, MA; Spalding, T; Viale, AM; Vila, AJ | 1 |
Hsiao, YJ; Hu, RM; Huang, SC; Lin, CW; Yang, TC | 1 |
Cantón, R; Giske, CG; Kahlmeter, G; Nordmann, P; Paterson, DL; Sundsfjord, AS; Walsh, TR; Woodford, N | 1 |
Aguilar, L; Alou, L; Cafini, F; Coronel, P; Giménez, MJ; González, N; Prieto, J; Sevillano, D; Torrico, M | 1 |
Bonomo, RA; Distler, AM; Endimiani, A; Hornick, JM; Hujer, AM; Hujer, KM; Papp-Wallace, KM; Taracila, M | 1 |
Geng, SN; Li, TY; Lu, SY; Ye, ZM; Zhang, DS; Zhang, YL; Zhou, HW; Zou, F | 1 |
Moldauer, L; Peterson, C; Riesenberg, R; Rosenthal, J | 1 |
Antunes, NT; Frase, H; Toth, M; Vakulenko, SB; Vakulenko, V | 1 |
Bonomo, RA; Papp-Wallace, KM; Smith, KM; Taracila, MA; Xu, Y | 1 |
He, L; Ke, H; Yuan, Q | 1 |
Drobniewski, F; Gonzalo, X | 1 |
Berbari, E; Huddleston, P; Ramos, A | 1 |
Ducho, C; Gomez-Castellanos, JR; Hamed, RB; Henry, L; McDonough, MA; Schofield, CJ | 1 |
Ahuja, V; Balasubramanian, V; Balganesh, M; Bhattacharjee, D; Dinesh, N; Ganguly, S; Kumar, N; Panduga, V; Parab, M; Ramachandran, V; Reddy, J; Shandil, R; Sharma, S; Solapure, S; Vishwas, KG | 1 |
Andersson, I; Blikstad, C; Demetriades, M; Dubus, A; Généreux, C; Hopkinson, RJ; Iqbal, A; Ivison, D; Kershaw, NJ; Lloyd, AJ; McDonough, MA; Roper, DI; Schofield, CJ; Valegård, K | 1 |
Arthur, M; Cordillot, M; Dubée, V; Dubost, L; Hugonnet, JE; Mainardi, JL; Marie, A; Triboulet, S | 1 |
Bhattacharyya, RP; Hung, DT; Wivagg, CN | 1 |
Kumar, M; Singhal, N; Srivastava, A; Virdi, JS | 1 |
Arthur, M; Ballell, L; Barros, D; Compain, F; Dubée, V; Hugonnet, JE; Li de la Sierra-Gallay, I; Mainardi, JL; Soroka, D; Triboulet, S; van Tilbeurgh, H | 1 |
Raghunand, TR; Viswanathan, G; Yadav, S | 1 |
Alffenaar, JC; Gumbo, T; Srivastava, S; van Rijn, SP; van Soolingen, D; Wessels, MA | 1 |
Ansari, M; Munir, T; Saad, N | 1 |
Chen, PY; Hu, RM; Huang, HH; Li, LH; Lin, YT; Yang, TC | 1 |
Calderón, C; M Munita, J; Martínez, F; Olivares, B; R Campodonico, P; Rivas, L | 1 |
Sharma, AK; Vats, P | 1 |
Chai, J; Chen, S; Cheng, Q; Wai Chi Chan, E; Xu, C; Zhang, R | 1 |
Cardoso, MH; Costa, BO; Franco, OL | 1 |
Abruzzi, J; Kopczynski, A; Montes, THM; Nedel, WL; Portela, LV; Rodolphi, MS; Strogulski, NR | 1 |
Alfandari, S; Bajolet, O; Blanchard, H; Colomb-Cotinat, M; Daniau, C; Dumartin, C; Lecuru, M; Simon, L | 1 |
10 review(s) available for clavulanic acid and beta-lactams
Article | Year |
---|---|
The role of beta-lactamase inhibitors in chemotherapy.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Chemical Phenomena; Chemistry; Clavulanic Acid; Clavulanic Acids; Gram-Negative Bacteria; Humans; Lactams; Penicillanic Acid; Sulfones | 1985 |
Naturally occurring beta-lactams.
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Lactams; Penicillins; Thienamycins | 1985 |
[Beta lactamase inhibitors, a new start of antibiotic therapy].
Topics: beta-Lactamase Inhibitors; beta-Lactams; Clavulanic Acid; Drug Resistance, Microbial; Humans; Kinetics; Penicillanic Acid; Sulbactam | 1982 |
Natural beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Cephalosporins; Cephamycins; Chemical Phenomena; Chemistry; Clavulanic Acid; Lactams; Penicillins; Thienamycins | 1980 |
Amoxycillin/clavulanic acid: a review of its antibacterial activity, pharmacokinetics and therapeutic use.
Topics: Amoxicillin; Animals; Bacteria; beta-Lactamase Inhibitors; beta-Lactams; Clavulanic Acid; Half-Life; Humans; Intestinal Absorption; Mice; Respiratory Tract Infections; Sexually Transmitted Diseases; Tissue Distribution; Urinary Tract Infections | 1981 |
[Bacterial resistance and pharmacodynamics as the basis for prescribing antibiotics in respiratory infections].
Topics: Amoxicillin; Anti-Bacterial Agents; Area Under Curve; Bacterial Infections; beta-Lactams; Clavulanic Acid; Dose-Response Relationship, Drug; Drug Resistance; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Haemophilus influenzae; Humans; Macrolides; Microbial Sensitivity Tests; Respiratory Tract Infections; Spain; Streptococcus pneumoniae | 2004 |
Diagnosis and treatment of Fusobacterium nucleatum discitis and vertebral osteomyelitis: case report and review of the literature.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Braces; Clavulanic Acid; Combined Modality Therapy; Discitis; Drug Therapy, Combination; Ertapenem; Female; Fusobacterium Infections; Fusobacterium nucleatum; Humans; Intervertebral Disc; Lumbar Vertebrae; Magnetic Resonance Imaging; Microbial Sensitivity Tests; Middle Aged; Osteomyelitis; Treatment Outcome | 2013 |
The enzymes of β-lactam biosynthesis.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; beta-Lactams; Cephalosporins; Clavulanic Acid; Humans; Mitosporic Fungi; Molecular Structure; Penicillins | 2013 |
Mechanisms of β-lactam killing and resistance in the context of Mycobacterium tuberculosis.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Clavulanic Acid; Drug Therapy, Combination; Humans; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant | 2014 |
Development of Peptides that Inhibit Aminoglycoside-Modifying Enzymes and β-Lactamases for Control of Resistant Bacteria.
Topics: Aminoglycosides; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Bacterial Infections; beta-Lactamases; beta-Lactams; Clavulanic Acid; Drug Design; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Kanamycin Kinase; Nucleotidyltransferases; Sulbactam; Tazobactam | 2020 |
4 trial(s) available for clavulanic acid and beta-lactams
Article | Year |
---|---|
Clavulanic acid and amoxycillin: a clinical, bacteriological, and pharmacological study.
Topics: Administration, Oral; Amoxicillin; Bacteriuria; beta-Lactamase Inhibitors; beta-Lactams; Biological Products; Carboxylic Acids; Clavulanic Acid; Clinical Trials as Topic; Drug Combinations; Enterobacteriaceae; Enterobacteriaceae Infections; Enzyme Inhibitors; Humans; Penicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Streptomyces; Tablets; Urinary Tract Infections | 1980 |
Treatment of chancroid by clavulanic acid with amoxycillin in patients with beta-lactamase-positive Haemophilus ducreyi infection.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Chancroid; Clavulanic Acid; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Enzyme Inhibitors; Haemophilus ducreyi; Humans; Male; Random Allocation | 1982 |
A controlled trial of amoxycillin with clavulanic acid (BRL 25000) against doxycycline in chronic bronchitis.
Topics: Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Bronchitis; Clavulanic Acid; Clinical Trials as Topic; Doxycycline; Drug Combinations; Humans; Middle Aged | 1981 |
Results of a proof-of-concept, dose-finding, double-blind, placebo-controlled study of RX-10100 (Serdaxin®) in subjects with major depressive disorder.
Topics: Adult; Antidepressive Agents; beta-Lactams; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Severity of Illness Index; Treatment Outcome | 2012 |
88 other study(ies) available for clavulanic acid and beta-lactams
Article | Year |
---|---|
Effect of clavulanic acid and amoxycillin formulation against beta-lactamase producing Gram-negative bacteria in urinary tract infections.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Clavulanic Acid; Escherichia coli; Female; Humans; Middle Aged; Proteus mirabilis; Urinary Tract Infections | 1979 |
Replacement of lysine 234 affects transition state stabilization in the active site of beta-lactamase TEM1.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Base Sequence; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Binding Sites; Clavulanic Acid; Clavulanic Acids; DNA, Bacterial; Enzyme Stability; Escherichia coli; Hydrogen-Ion Concentration; Kinetics; Lysine; Molecular Sequence Data; Mutagenesis, Site-Directed | 1991 |
'Beta-lactams' as beta-lactamase inhibitors.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Cephalosporins; Clavulanic Acid; Drug Evaluation, Preclinical; Drug Synergism; Lactams; Penicillins | 1980 |
Beta-lactamase inactivation by mechanism-based reagents.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Clavulanic Acid; Lactams; Penicillanic Acid; Sulbactam | 1980 |
Clavulanic acid and CP-45,899: a comparison of their in vitro activity in combination with penicillins.
Topics: Bacteria; Bacteroides fragilis; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Clavulanic Acid; Enterobacteriaceae; Haemophilus influenzae; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillanic Acid; Penicillins; Pseudomonas aeruginosa; Staphylococcus aureus; Sulbactam | 1980 |
Synergistic activity of piperacillin in combination with beta-lactamase inhibitors.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; beta-Lactams; Clavulanic Acid; Drug Synergism; Penicillanic Acid; Penicillins; Piperacillin; Sulbactam | 1980 |
6-beta-bromo- and 6-beta-iodo penicillanic acid, two novel beta-lactamase inhibitors.
Topics: Ampicillin; Bacteria; beta-Lactamase Inhibitors; beta-Lactams; Clavulanic Acid; Penicillanic Acid | 1981 |
Synergistic activity of cefoperazone in combination with beta-lactamase inhibitors.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; beta-Lactams; Cefoperazone; Cefotaxime; Cephalosporins; Clavulanic Acid; Drug Synergism; Penicillanic Acid; Sulbactam | 1981 |
Synthesis and beta-lactamase inhibitory properties of 2 beta-(chloromethyl)-2 alpha-methylpenam-3 alpha-carboxylic acid 1,1-dioxide.
Topics: Amoxicillin; Animals; beta-Lactamase Inhibitors; beta-Lactams; Chemical Phenomena; Chemistry; Clavulanic Acid; Escherichia coli Infections; Mice; Mice, Inbred ICR; Penicillanic Acid; Staphylococcal Infections; Staphylococcus aureus | 1981 |
Interaction between non-classical beta-lactam compounds and the Zn2+-containing G and serine R61 and R39 D-alanyl-D-alanine peptidases.
Topics: Actinomycetaceae; Amdinocillin; beta-Lactams; Carboxypeptidases; Cefoxitin; Cephalosporins; Clavulanic Acid; Drug Interactions; Endopeptidases; Enzyme Inhibitors; Imipenem; Kinetics; Penicillanic Acid; Penicillins; Quinoxalines; Serine-Type D-Ala-D-Ala Carboxypeptidase; Streptomyces; Zinc | 1981 |
The effect of inhibitors of beta-lactamases on beta-lactamase extracts and on intact cells.
Topics: Ampicillin; Bacteria; beta-Lactamase Inhibitors; beta-Lactams; Cephaloridine; Clavulanic Acid; Hydrolysis; Microbial Sensitivity Tests; Penicillanic Acid; Sulbactam | 1982 |
Comparative activity in vitro of piperacillin.
Topics: Bacteria; Bacterial Infections; beta-Lactamases; beta-Lactams; Clavulanic Acid; Drug Stability; Drug Synergism; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin; R Factors | 1982 |
Combinations of clavulanic acid and other beta-lactam antibiotics against strains of Pseudomonas aeruginosa, Serratia marcescens and other bacteria.
Topics: beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cephalosporins; Clavulanic Acid; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae; Enzyme Inhibitors; Pseudomonas aeruginosa; Serratia marcescens; Staphylococcus aureus | 1980 |
Inhibition of beta-lactamase in penicillinase producing gonococci by clavulanic acid.
Topics: beta-Lactamase Inhibitors; beta-Lactams; Clavulanic Acid; Neisseria gonorrhoeae | 1981 |
The combination of clavulanic acid and amoxycillin (Augmentin) in the treatment of patients infected with penicillinase producing gonococci.
Topics: Amoxicillin; beta-Lactamases; beta-Lactams; Clavulanic Acid; Drug Therapy, Combination; Gonorrhea; Humans; Neisseria gonorrhoeae; Penicillinase | 1981 |
Initial results of in vitro studies of clavulanic acid synergism.
Topics: Ampicillin; Bacteria; beta-Lactamase Inhibitors; beta-Lactams; Carbenicillin; Clavulanic Acid; Drug Synergism; Penicillins | 1981 |
Twenty-one years of beating beta-lactamases.
Topics: Amoxicillin; beta-Lactamase Inhibitors; beta-Lactams; Cephalosporins; Clavulanic Acid; Humans; Penicillin Resistance | 1982 |
In vitro activity of BRL 17421 against Haemophilus influenzae, Neisseria gonorrhoeae, and Branhamella catarrhalis.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacteria; beta-Lactamases; beta-Lactams; Clavulanic Acid; Haemophilus influenzae; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Neisseriaceae; Penicillins | 1982 |
Combined antibacterial activity of amoxicillin with clavulanic acid against ampicillin-resistant strains.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; beta-Lactams; Clavulanic Acid; Drug Synergism; Kinetics; Penicillin Resistance | 1980 |
In vitro synergistic properties of clavulanic acid, with ampicillin, amoxycillin and ticarcillin.
Topics: Amoxicillin; Ampicillin; Bacteria; beta-Lactamases; beta-Lactams; Clavulanic Acid; Drug Synergism; Humans; Penicillins; Protein Binding; Ticarcillin | 1980 |
Effect of clavulanic acid on minimal inhibitory concentrations of 16 antimicrobial agents tested against Legionella pneumophila.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Clavulanic Acid; Drug Synergism; Legionella; Microbial Sensitivity Tests | 1980 |
Clavulanic acid and respiratory infection.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Clavulanic Acid; Humans; Respiratory Tract Infections | 1981 |
[Indicator method of determining the beta-lactamase-inhibiting activity of various compounds].
Topics: Actinomycetales; Anti-Bacterial Agents; Bacillus; beta-Lactamase Inhibitors; beta-Lactams; Clavulanic Acid; Enzyme Activation; Indicators and Reagents; Methods; Time Factors | 1981 |
Synergistic antibacterial activity of clavulanic acid and amoxicillin against beta-lactamase-producing strains of Haemophilus ducreyi.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Clavulanic Acid; Drug Synergism; Haemophilus | 1981 |
Interaction of beta-lactamase of Streptomyces cacaoi. I. Clavulanic acid and PS-5.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Clavulanic Acid; Streptomyces; Thienamycins | 1981 |
Interactions between non-classical beta-lactam compounds and the beta-lactamases of Actinomadura R39 and Streptomyces albus G.
Topics: Actinomycetaceae; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Clavulanic Acid; Hydrolysis; Imipenem; Kinetics; Streptomyces | 1981 |
Pharmacokinetics of potassium clavulanate in combination with amoxicillin in pediatric patients.
Topics: Amoxicillin; beta-Lactams; Child; Clavulanic Acid; Drug Combinations; Half-Life; Humans; Kinetics; Penicillinase; Suspensions; Time Factors | 1982 |
The history and background of Augmentin.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Chemical Phenomena; Chemistry; Clavulanic Acid; Drug Combinations; Enzyme Inhibitors; Penicillin Resistance | 1982 |
The in vitro activity of amoxycillin with clavulanic acid against clinically significant bacteria. A multicentre study.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; beta-Lactams; Clavulanic Acid; Dose-Response Relationship, Drug; Drug Combinations; Enzyme Inhibitors; Penicillin Resistance | 1982 |
[Treatment with amoxicillin and clavulanic acid of urinary tract infections in patients with spinal injuries].
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Clavulanic Acid; Drug Combinations; Enzyme Inhibitors; Humans; Spinal Injuries; Urinary Tract Infections | 1982 |
Amoxicillin and clavulanic acid combination: clinical and laboratory evaluation in pulmonary infections.
Topics: Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; beta-Lactamases; beta-Lactams; Bronchitis; Clavulanic Acid; Drug Combinations; Humans; Microbial Sensitivity Tests; Middle Aged; Pneumonia | 1982 |
beta-Lactamases of Branhamella catarrhalis and their inhibition by clavulanic acid.
Topics: Aerobiosis; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Clavulanic Acid; Isoelectric Focusing; Neisseria | 1982 |
A study of clavulanate-amoxicillin synergy using a triple layer technique and enzymatic neutralization.
Topics: Amoxicillin; Bacteria; Bacteriological Techniques; beta-Lactamase Inhibitors; beta-Lactams; Clavulanic Acid; Culture Media; Drug Synergism; Penicillinase | 1980 |
Inactivation of RTEM beta-lactamase from Escherichia coli by clavulanic acid and 9-deoxyclavulanic acid.
Topics: beta-Lactamase Inhibitors; beta-Lactams; Clavulanic Acid; Clavulanic Acids; Escherichia coli; Kinetics; Magnetic Resonance Spectroscopy; Mass Spectrometry; Spectrophotometry, Ultraviolet | 1981 |
The inhibition of beta-lactamases from gram-negative bacteria by clavulanic acid.
Topics: beta-Lactamase Inhibitors; beta-Lactams; Clavulanic Acid; Enterobacteriaceae; Enzyme Inhibitors; Escherichia coli; Kinetics; Substrate Specificity | 1981 |
Susceptibility of Yersinia enterocolitica to eight beta-lactam antibiotics and clavulanic acid.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactams; Clavulanic Acid; Drug Interactions; Humans; Microbial Sensitivity Tests; Penicillin G; Yersinia; Yersinia Infections | 1981 |
Use of the chromosomal class A beta-lactamase of Mycobacterium fortuitum D316 to study potentially poor substrates and inhibitory beta-lactam compounds.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Chromosomes, Bacterial; Clavulanic Acid; Clavulanic Acids; Kinetics; Lactams; Mycobacterium | 1994 |
Interactions between active-site-serine beta-lactamases and mechanism-based inactivators: a kinetic study and an overview.
Topics: Actinomycetales; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Binding Sites; Clavulanic Acid; Clavulanic Acids; Hydrolysis; Kinetics; Lactams; Serine; Streptomyces; Sulbactam | 1993 |
In-vitro evaluation of the four beta-lactamase inhibitors: BRL42715, clavulanic acid, sulbactam, and tazobactam.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Escherichia coli; Lactams; Microbial Sensitivity Tests; Penicillanic Acid; Sulbactam; Tazobactam | 1993 |
Effect of five irreversible inhibitors on beta-lactamase from Shigella flexneri UCSF-129.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Clavulanic Acid; Clavulanic Acids; Drug Synergism; Lactams; Microbial Sensitivity Tests; Penicillanic Acid; Shigella flexneri | 1993 |
Activity of 13 beta-lactam agents combined with BRL 42715 against beta-lactamase producing gram-negative bacteria compared to combinations with clavulanic acid, tazobactam and sulbactam.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Clavulanic Acid; Clavulanic Acids; Drug Therapy, Combination; Enzyme Inhibitors; Gram-Negative Bacteria; Lactams; Penicillanic Acid; Sulbactam; Tazobactam | 1993 |
Synthesis and antimicrobial evaluation of 2 beta-chloromethyl-6 beta-carbamoylmethyl-penam-1,1-dioxide-3-carboxylic acid.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; beta-Lactams; Clavulanic Acid; Clavulanic Acids; Enzyme Inhibitors; Lactams; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Penicillins; Staphylococcus aureus | 1996 |
Design, synthesis, and evaluation of 2 beta-alkenyl penam sulfone acids as inhibitors of beta-lactamases.
Topics: beta-Lactamase Inhibitors; beta-Lactams; Ceftriaxone; Citrobacter freundii; Clavulanic Acid; Clavulanic Acids; Crystallography, X-Ray; Drug Design; Drug Synergism; Enterobacter; Enzyme Inhibitors; Lactams; Models, Molecular; Molecular Structure; Pseudomonas; Spectrophotometry, Ultraviolet | 1996 |
Characterization of the inoculum effect with Haemophilus influenzae and beta-lactams.
Topics: Anti-Bacterial Agents; beta-Lactams; Clavulanic Acid; Colony Count, Microbial; Haemophilus influenzae; Humans; Microbial Sensitivity Tests | 1999 |
Aspartic acid for asparagine substitution at position 276 reduces susceptibility to mechanism-based inhibitors in SHV-1 and SHV-5 beta-lactamases.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; Asparagine; Aspartic Acid; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Clavulanic Acid; Enzyme Inhibitors; Escherichia coli; Inhibitory Concentration 50; Microbial Sensitivity Tests; Penicillanic Acid; Sulbactam; Tazobactam | 1999 |
Penetration of beta-lactamase inhibitors into the periplasm of gram-negative bacteria.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Cell Membrane Permeability; Clavulanic Acid; Enterobacter cloacae; Enzyme Inhibitors; Escherichia coli; Gram-Negative Bacteria; Klebsiella pneumoniae; Lactams; Penicillanic Acid; Periplasm; Sulbactam; Tazobactam | 1999 |
Performance of methods for detection of extended-spectrum beta-lactamases applied to clinical enterobacterial strains producing IBC-type beta-lactamases.
Topics: beta-Lactamases; beta-Lactams; Ceftazidime; Clavulanic Acid; Drug Combinations; Drug Resistance, Bacterial; Enterobacteriaceae; Humans; Microbial Sensitivity Tests | 2003 |
In vitro activities of novel oxapenems, alone and in combination with ceftazidime, against gram-positive and gram-negative organisms.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Ceftazidime; Cephalosporins; Clavulanic Acid; Drug Synergism; Enterococcus faecalis; Enzyme Inhibitors; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; Lactams; Microbial Sensitivity Tests; Staphylococcus aureus | 2003 |
Understanding resistance to beta-lactams and beta-lactamase inhibitors in the SHV beta-lactamase: lessons from the mutagenesis of SER-130.
Topics: Ampicillin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Binding, Competitive; Clavulanic Acid; Drug Resistance, Microbial; Enzyme Inhibitors; Escherichia coli; Kinetics; Models, Chemical; Mutagenesis; Mutagenesis, Site-Directed; Penicillanic Acid; Plasmids; Serine; Tazobactam; Thermodynamics; Time Factors | 2003 |
[Phenotypes of beta-lactam resistance in the genus Aeromonas].
Topics: Aeromonas; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Clavulanic Acid; Enzyme Inhibitors; Isoelectric Focusing; Isoelectric Point; Lactams; Microbial Sensitivity Tests; Penicillanic Acid; Phenotype; Tazobactam | 2003 |
Pharmacodynamic study of beta-lactams alone and in combination with beta-lactamase inhibitors against Pseudomonas aeruginosa possessing an inducible beta-lactamase.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Clavulanic Acid; Colony Count, Microbial; Drug Synergism; Enzyme Induction; Enzyme Inhibitors; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits | 2004 |
[E. coli: resistance to quinolones and beta-lactams of clinical strains isolated in the Franche-Comté region of France].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Ceftazidime; Cephalothin; Ciprofloxacin; Clavulanic Acid; Community-Acquired Infections; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Utilization; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; France; Genotype; Humans; Male; Middle Aged; Nalidixic Acid; Phenotype; Selection, Genetic; Urinary Tract Infections | 2004 |
The vitro efficacy of beta-lactam and beta-lactamase inhibitors against multidrug resistant clinical strains of Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Clavulanic Acid; Culture Media; Drug Resistance, Multiple, Bacterial; Enzyme Inhibitors; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2004 |
In vitro activities of the beta-lactamase inhibitors clavulanic acid, sulbactam, and tazobactam alone or in combination with beta-lactams against epidemiologically characterized multidrug-resistant Acinetobacter baumannii strains.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Clavulanic Acid; DNA; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Electrophoresis, Gel, Pulsed-Field; Enzyme Inhibitors; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Sulbactam; Tazobactam | 2004 |
Antibiotic susceptibility of coagulase-negative staphylococci isolated from goats' milk.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Clavulanic Acid; Food Microbiology; Goat Diseases; Goats; Kanamycin; Macrolides; Mastitis; Microbial Sensitivity Tests; Milk; Staphylococcal Infections; Staphylococcus; Staphylococcus epidermidis; Tetracycline | 2004 |
A Bacteroides thetaiotamicron porin that could take part in resistance to beta-lactams.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacteroides; beta-Lactam Resistance; beta-Lactams; Clavulanic Acid; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Porins | 2004 |
Differential effects of beta-lactams on human IFN-gamma activity.
Topics: Anti-Bacterial Agents; beta-Lactams; Cell Line; Clavulanic Acid; Epithelial Cells; Humans; Immunologic Factors; Intercellular Adhesion Molecule-1; Interferon-gamma; Penicillin G; Time Factors | 2005 |
Enhancement of antimicrobial activities of cefteram or clavulanic acid/amoxicillin against cefixime-resistant Neisseria gonorrhoeae in the presence of clarithromycin or azithromycin.
Topics: Amoxicillin; Anti-Bacterial Agents; Azithromycin; beta-Lactams; Cefixime; Cefmenoxime; Clarithromycin; Clavulanic Acid; Drug Resistance, Bacterial; Drug Synergism; Erythromycin; Humans; Male; Neisseria gonorrhoeae | 2006 |
Susceptibilities of ESBL-producing Enterobacteriaceae to ertapenem, meropenem and piperacillin-tazobactam with and without clavulanic acid.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Clavulanic Acid; Drug Interactions; Ertapenem; Escherichia coli; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Thienamycins | 2007 |
Identification of the novel narrow-spectrum beta-lactamase SCO-1 in Acinetobacter spp. from Argentina.
Topics: Acinetobacter; Acinetobacter Infections; Amino Acid Sequence; Anti-Bacterial Agents; Argentina; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Clavulanic Acid; Cloning, Molecular; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA | 2007 |
Sensitivity and specificity of various beta-lactam antibiotics and phenotypical methods for detection of TEM, SHV and CTX-M extended-spectrum beta-lactamases.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cells, Cultured; Clavulanic Acid; Drug Synergism; Escherichia coli; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Phenotype; Sensitivity and Specificity | 2007 |
Raman crystallographic studies of the intermediates formed by Ser130Gly SHV, a beta-lactamase that confers resistance to clinical inhibitors.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Clavulanic Acid; Crystallography, X-Ray; Enzyme Inhibitors; Glycine; Penicillanic Acid; Serine; Spectrum Analysis, Raman; Stereoisomerism; Tazobactam | 2007 |
TEM-158 (CMT-9), a new member of the CMT-type extended-spectrum beta-lactamases.
Topics: beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Catalysis; Ceftazidime; Clavulanic Acid; Escherichia coli; Escherichia coli Proteins; Isoenzymes; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA | 2007 |
Sensitivity pattern of gram negative bacilli to three beta-lactam/beta-lactamase inhibitor combinations using the automated API system.
Topics: Acinetobacter; Amoxicillin; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactams; Clavulanic Acid; Enterobacteriaceae; Enzyme Inhibitors; Gram-Negative Bacteria; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Pseudomonas; Stenotrophomonas; Tazobactam; Ticarcillin | 2007 |
A convenient microbiological assay employing cell-free extracts for the rapid characterization of Gram-negative carbapenemase producers.
Topics: Bacterial Proteins; Bacteriological Techniques; Bacteriolysis; beta-Lactamases; beta-Lactams; Clavulanic Acid; Complex Mixtures; Edetic Acid; Enzyme Inhibitors; Gram-Negative Bacteria; Microspheres; Silicon Dioxide; Substrate Specificity | 2008 |
Induction potential of clavulanic acid toward L1 and L2 beta-lactamases of Stenotrophomonas maltophilia.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Clavulanic Acid; Enzyme Induction; Humans; Microbial Sensitivity Tests; Stenotrophomonas maltophilia | 2008 |
Redefining extended-spectrum beta-lactamases: balancing science and clinical need.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Clavulanic Acid; Enzyme Inhibitors; Gram-Negative Bacteria; Humans; Substrate Specificity; Terminology as Topic | 2009 |
Beta-lactam effects on mixed cultures of common respiratory isolates as an approach to treatment effects on nasopharyngeal bacterial population dynamics.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cells, Cultured; Clavulanic Acid; Computer Simulation; Haemophilus influenzae; Nasopharynx; Respiratory Tract Infections; Streptococcus pneumoniae | 2008 |
Substrate selectivity and a novel role in inhibitor discrimination by residue 237 in the KPC-2 beta-lactamase.
Topics: Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cephalosporinase; Clavulanic Acid; Computer Simulation; Enzyme Inhibitors; Hydrogen Bonding; Kinetics; Microbial Sensitivity Tests; Molecular Structure; Mutagenesis, Site-Directed; Penicillanic Acid; Protein Structure, Secondary; Spectrometry, Mass, Electrospray Ionization; Substrate Specificity; Sulbactam; Tazobactam | 2010 |
High diversity of extended-spectrum beta-lactamase-producing bacteria in an urban river sediment habitat.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Proteins; beta-Lactamases; beta-Lactams; China; Clavulanic Acid; Cluster Analysis; DNA, Bacterial; DNA, Ribosomal; Ecosystem; Genetic Variation; Geologic Sediments; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Rivers; RNA, Ribosomal, 16S; Sequence Analysis, DNA | 2010 |
Class A carbapenemase FPH-1 from Francisella philomiragia.
Topics: Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Clavulanic Acid; Doripenem; Ertapenem; Escherichia coli; Francisella; Imipenem; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Sulbactam; Tazobactam; Thienamycins | 2012 |
Understanding the molecular determinants of substrate and inhibitor specificities in the Carbapenemase KPC-2: exploring the roles of Arg220 and Glu276.
Topics: Amino Acid Sequence; Amino Acid Substitution; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Catalytic Domain; Clavulanic Acid; Klebsiella pneumoniae; Microbial Sensitivity Tests; Protein Structure, Quaternary; Sequence Analysis, Protein; Structure-Activity Relationship | 2012 |
A potential substrate binding conformation of β-lactams and insight into the broad spectrum of NDM-1 activity.
Topics: beta-Lactamases; beta-Lactams; Catalytic Domain; Clavulanic Acid; Klebsiella pneumoniae; Moxalactam; Protein Binding; Protein Conformation | 2012 |
Is there a place for β-lactams in the treatment of multidrug-resistant/extensively drug-resistant tuberculosis? Synergy between meropenem and amoxicillin/clavulanate.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Clavulanic Acid; Drug Synergism; Humans; Meropenem; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Thienamycins; Tuberculosis, Multidrug-Resistant | 2013 |
In vitro and in vivo efficacy of β-lactams against replicating and slowly growing/nonreplicating Mycobacterium tuberculosis.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; beta-Lactams; Clavulanic Acid; Disease Models, Animal; Drug Therapy, Combination; Female; Humans; Meropenem; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Streptomycin; Thienamycins; Treatment Outcome; Tuberculosis, Pulmonary | 2013 |
Structural and mechanistic studies of the orf12 gene product from the clavulanic acid biosynthesis pathway.
Topics: Amino Acid Motifs; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carboxypeptidases; Catalytic Domain; Cephalosporins; Clavulanic Acid; Crystallography, X-Ray; Hydrolysis; Models, Molecular; Penicillins; Protein Conformation; Protein Structure, Tertiary; Serine; Streptomyces | 2013 |
In vitro cross-linking of Mycobacterium tuberculosis peptidoglycan by L,D-transpeptidases and inactivation of these enzymes by carbapenems.
Topics: Antitubercular Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Cell Wall; Clavulanic Acid; Doripenem; Enzyme Assays; Ertapenem; Escherichia coli; Gene Expression; Imipenem; Kinetics; Meropenem; Mycobacterium tuberculosis; Peptidoglycan; Peptidyl Transferases; Recombinant Proteins; Thienamycins | 2013 |
Structural Variabilities in β-Lactamase (blaA) of Different Biovars of Yersinia enterocolitica: Implications for β-Lactam Antibiotic and β-Lactamase Inhibitor Susceptibilities.
Topics: Amino Acid Substitution; Amoxicillin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactams; Clavulanic Acid; DNA-Binding Proteins; Drug Resistance, Bacterial; Gene Expression Regulation, Bacterial; Hydrogen Bonding; Models, Molecular; Molecular Docking Simulation; Nucleic Acid Conformation; Promoter Regions, Genetic; RNA, Messenger; Yersinia enterocolitica | 2014 |
Hydrolysis of clavulanate by Mycobacterium tuberculosis β-lactamase BlaC harboring a canonical SDN motif.
Topics: beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Clavulanic Acid; Microbial Sensitivity Tests; Mycobacterium tuberculosis | 2015 |
Identification of Mycobacterial Genes Involved in Antibiotic Sensitivity: Implications for the Treatment of Tuberculosis with β-Lactam-Containing Regimens.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Clavulanic Acid; Dibenzothiepins; Drug Resistance, Microbial; Meropenem; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Thienamycins; Tuberculosis | 2017 |
Sterilizing Effect of Ertapenem-Clavulanate in a Hollow-Fiber Model of Tuberculosis and Implications on Clinical Dosing.
Topics: Antitubercular Agents; beta-Lactams; Clavulanic Acid; Computer Simulation; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ertapenem; Humans; Microbial Sensitivity Tests; Monte Carlo Method; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant | 2017 |
Phenotypic Identification, Frequency Distribution and Antibiogram of Carbapenemase Producing Enterobacteriaceae in Clinical Isolates.
Topics: Amoxicillin; Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenem-Resistant Enterobacteriaceae; Clavulanic Acid; Disk Diffusion Antimicrobial Tests; Enterobacteriaceae Infections; Humans; Sensitivity and Specificity | 2018 |
Impacts of L1 Promoter Variation and L2 Clavulanate Susceptibility on Ticarcillin-Clavulanate Susceptibility of Stenotrophomonas maltophilia.
Topics: Alleles; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Clavulanic Acid; Genetic Variation; Humans; Microbial Sensitivity Tests; Phylogeny; Promoter Regions, Genetic; Stenotrophomonas maltophilia; Ticarcillin | 2018 |
A Natural Deep Eutectic Solvent Formulated to Stabilize β-Lactam Antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Betaine; Carbon-13 Magnetic Resonance Spectroscopy; Clavulanic Acid; Escherichia coli; Imipenem; Microbial Sensitivity Tests; Proton Magnetic Resonance Spectroscopy; Pseudomonas aeruginosa; Solvents; Spectroscopy, Fourier Transform Infrared; Urea; Vibration; Water | 2018 |
Evaluation of biochemical and molecular polymorphism in extended spectrum β-lactamases of Mycobacterium tuberculosis clinical isolates.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Blotting, Southern; Cefotaxime; Cephalosporins; Clavulanic Acid; Humans; Isoelectric Focusing; Kinetics; Mycobacterium tuberculosis; Polymerase Chain Reaction; Tuberculosis | 2019 |
Structural Insight into the Mechanism of Inhibitor Resistance in CTX-M-199, a CTX-M-64 Variant Carrying the S
Topics: Amino Acid Substitution; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Binding Sites; Catalytic Domain; Clavulanic Acid; Crystallography; Drug Resistance, Multiple, Bacterial; Hydrolysis; Mass Spectrometry; Models, Molecular; Sulbactam | 2020 |
Antibiotic therapy does not alter mitochondrial bioenergetics in lymphocytes of patients with septic shock - A prospective cohort study.
Topics: Amoxicillin; Anti-Bacterial Agents; Azithromycin; beta-Lactams; Clavulanic Acid; Energy Metabolism; Humans; Lymphocytes; Meropenem; Mitochondria; Piperacillin, Tazobactam Drug Combination; Polymyxins; Prospective Studies; Shock, Septic; Vancomycin | 2022 |
Evolution of antibiotic treatments for healthcare-associated infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae in France.
Topics: Aminoglycosides; Amoxicillin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Clavulanic Acid; Cross Infection; Delivery of Health Care; Enterobacteriaceae; Enterobacteriaceae Infections; France; Humans; Nitrofurantoin; Ofloxacin; Penicillins; Urinary Tract Infections | 2022 |